Amwell® Simplifies Telehealth Access with Amwell Now and Expanded Carepoint™ Portfolio

New offerings enable increased doctor-to-patient virtual connectivity, helping providers adopt and health systems scale telehealth across specialties

Amwell® (NYSE: AMWL), a national telehealth leader, today announced new connectivity, device and cart offerings, all tailored to meet the evolving needs of care teams and patients. Spurred by the impact of the COVID-19 pandemic, Amwell is introducing Amwell Now, new Touchpoint Tablet software, and the C500 telemedicine cart to help health systems and other healthcare organizations easily leverage telehealth as a safe, quality care option.

“Amid COVID-19, healthcare organizations’ needs for and expectations surrounding telehealth have fundamentally changed,” said Ido Schoenberg, Chairman and Co-CEO, Amwell. “Increasingly, virtual care is being used as core to all types of care delivery, whether it’s to safeguard care teams, limit unnecessary exposure for patients, or to prioritize the home as a go-to care setting. Our latest offerings are responsive to industry calls for simplicity, integration, and quality, and in service to the evolving landscape of healthcare and our lives overall.”

Amwell Now and Amwell’s latest Carepoint tablets and carts are designed to make it easier for providers to quickly onboard patients and use virtual care. These tools can be integrated within and scaled across organizations’ current systems and devices, making it simple to embed and launch telehealth across various specialties and serve an entire care organization. New offerings include:

  • Amwell Now – Amwell Now enables a simple connectivity experience for patients and providers, streamlining entry to the Amwell platform, which is purposefully designed for healthcare interactions. Amwell Now addresses physicians’ needs for easy, fast video visits, all on Amwell’s HIPAA compliant, clinically tailored platform. It delivers simple reporting functionality and the ability for organizations to put forward their own brand versus that of Amwell. Providers can deploy Amwell Now with only a few clicks, invite patients by text or email, launch an instant video connection, and experience an adaptable video visit workflow that is easy for both themselves and their patients. More information on Amwell Now can be found here.
  • Touchpoint Tablet Software – Amwell’s Touchpoint Tablet software offers a new and simple way to connect remote providers to on-site patients and providers. With it, health systems can use (existing or new) iPads to facilitate bedside video connectivity and collaboration in a secure, reliable, HIPAA-compliant way. The Touchpoint Tablet software is integrated with Amwell Fleet Monitoring, enabling health systems to track their tablets as part of their Carepoint fleet. To learn more about Touchpoint Tablet software, click here.
  • C500 – The C500 is Amwell’s latest-generation, lightweight telemedicine cart that empowers providers to conduct efficient, high-quality remote exams across a variety of specialties. Featuring an embedded 4K camera that responds immediately to user commands and smart sensors that make the cart environment-aware, the C500 provides a seamless care experience that is fully integrated with the Amwell telehealth platform. To learn more about the C500, click here.

More information about Amwell’s full Carepoint portfolio can be found here: https://business.amwell.com/telemedicine-equipment/

About Amwell

Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives. For more information please visit https://business.amwell.com/.

American Well, Amwell and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release.  These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in the prospectus for our IPO filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.